We are live on !
Find out more
Bellecapital Portfolio holdings
AUM
$625M
Turnover
41.45%
1-Year Est. Return
39.69%
This Fund
S&P 500
This Quarter Est. Return
-11.73%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$358M
AUM Growth
+$43.1M
(+14%)
Cap. Flow
+$77.7M
Cap. Flow % of AUM
Cap. Flow %
21.67%
Top 10 Holdings %
Top 10 Hldgs %
35.25%
Holding
226
New
24
Increased
46
Reduced
62
Closed
24
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
|
+$17.1M |
| 2 |
Vanguard Total World Stock ETF
VT
|
+$13.5M |
| 3 |
Walmart Inc
WMT
|
+$9.42M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$8.71M |
| 5 |
Microsoft
MSFT
|
+$7.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Health Catalyst
HCAT
|
+$1.88M |
| 2 |
Chevron
CVX
|
+$1.45M |
| 3 |
Vail Resorts
MTN
|
+$1.34M |
| 4 |
BSJM
Invesco BulletShares 2022 High Yield Corporate Bond ETF
BSJM
|
+$799K |
| 5 |
AbbVie
ABBV
|
+$757K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.11% |
| 2 | Technology | 18.1% |
| 3 | Healthcare | 13.47% |
| 4 | Consumer Staples | 13.16% |
| 5 | Consumer Discretionary | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Progressive
PGR
$127B
| $416K | 0.12% |
3,576
-100
| -3% | -$11.3K |
2019 Q4
10 quarters
|
|
|
127
Alphabet (Google) Class C
GOOG
$4.12T
| $403K | 0.11% |
+73,680
| New | +$8.71M |
2022 Q2
0 quarters
|
|
128
Valhi
VHI
$416M
| $396K | 0.11% |
+8,745
| New | +$348K |
2022 Q2
0 quarters
|
|
|
IBHB
129
DELISTED
iShares iBonds 2022 Term High Yield and Income ETF
IBHB
| $393K | 0.11% |
16,365
| – | – |
2020 Q4
6 quarters
|
|
130
Boeing
BA
$150B
| $381K | 0.11% |
2,788
-145
| -5% | -$21.4K |
2020 Q2
8 quarters
|
|
131
Visa
V
$756B
| $381K | 0.11% |
1,937
-19
| -1% | -$3.93K |
2020 Q4
6 quarters
|
|
132
Shell
SHEL
$303B
| $376K | 0.1% |
7,197
-1,400
| -16% | -$78.7K |
2022 Q1
1 quarter
|
|
133
Mondelez International
MDLZ
$81.6B
| $372K | 0.1% |
5,999
-150
| -2% | -$9.48K |
2019 Q1
13 quarters
|
|
134
Kroger
KR
$37.6B
| $367K | 0.1% |
7,756
| – | – |
2021 Q3
3 quarters
|
|
135
AMN Healthcare
AMN
$1.57B
| $366K | 0.1% |
3,340
| – | – |
2021 Q3
3 quarters
|
|
136
Array Technologies
ARRY
$528M
| $363K | 0.1% |
32,985
+229
| +0.7% | +$2.26K |
2021 Q2
4 quarters
|
|
137
Cencora
COR
$65.1B
| $361K | 0.1% |
2,554
| – | – |
2021 Q3
3 quarters
|
|
138
Idacorp
IDA
$8B
| $336K | 0.09% |
3,174
| – | – |
2021 Q1
5 quarters
|
|
139
Abbott
ABT
$181B
| $333K | 0.09% |
3,061
| – | – |
2020 Q3
7 quarters
|
|
140
TSMC
TSM
$2.14T
| $328K | 0.09% |
4,016
-412
| -9% | -$38.1K |
2020 Q3
7 quarters
|
|
|
ARCE
141
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $321K | 0.09% |
21,524
+644
| +3% | +$11.3K |
2021 Q1
5 quarters
|
|
|
142
Health Catalyst
HCAT
$130M
| $319K | 0.09% |
22,020
-110,035
| -83% | -$1.88M |
2020 Q4
6 quarters
|
|
143
Merck
MRK
$360B
| $318K | 0.09% |
3,490
| – | – |
2018 Q4
14 quarters
|
|
144
Invesco QQQ Trust
QQQ
$475B
| $317K | 0.09% |
1,132
| – | – |
2019 Q2
12 quarters
|
|
145
iShares Biotechnology ETF
IBB
$10.3B
| $314K | 0.09% |
2,670
| – | – |
2021 Q4
2 quarters
|
|
146
Assurant
AIZ
$14B
| $309K | 0.09% |
1,789
| – | – |
2022 Q1
1 quarter
|
|
147
Artesian Resources
ARTNA
$345M
| $307K | 0.09% |
6,249
| – | – |
2022 Q1
1 quarter
|
|
148
Hanmi Financial
HAFC
$923M
| $307K | 0.09% |
13,660
| – | – |
2021 Q4
2 quarters
|
|
149
Home Depot
HD
$309B
| $300K | 0.08% |
1,094
| – | – |
2019 Q2
12 quarters
|
|
150
Freeport-McMoran
FCX
$100B
| $294K | 0.08% |
10,050
| – | – |
2020 Q4
6 quarters
|
|
Similar funds
BVC
APM
PAS
Bellecapital's Q2 2022 Portfolio in Review
As of Q2 2022, Bellecapital held 226 positions worth $358M, up 14% from $315M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Bellecapital deployed $77.7M of net new capital in Q2 2022, opening 24 new positions and adding to 46 existing holdings. Its largest new stake was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 669,939 shares worth $17M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Health Catalyst, an estimated $1.88M trimmed.
- Bellecapital's largest Q2 2022 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 669,939 shares worth $17M.
- Bellecapital added most to Walmart Inc in Q2 2022, an estimated $9.42M increase.
- Bellecapital's biggest Q2 2022 reduction was Health Catalyst, cutting an estimated $1.88M.
- Bellecapital fully exited Chevron in Q2 2022, selling an estimated $1.45M.
- Bellecapital's ten largest holdings make up 35% of its $358M portfolio in Q2 2022.
- Bellecapital opened 24 new positions and closed 24 in Q2 2022.
- Bellecapital's portfolio value rose 14% quarter-over-quarter to $358M.
Based on Bellecapital's 13F filing for Q2 2022, filed 27 Jul 2022.